Jean-Michel Vallat

发表

Nutritional status is a prognostic factor for survival in ALS patients

D. Sautereau, P. Preux, J. Vallat, 1999, Neurology.

Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors.

P. Preux, J. Vallat, J. Salle, 1996, Neuroepidemiology.

Inducible nitric oxide synthase and nitrotyrosine in the central nervous system of mice chronically infected with Trypanosoma brucei brucei.

J. Vallat, A. Buguet, P. Vincendeau, 2000, Experimental parasitology.

Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy

R. Hughes, K. Dawson, J. Pollard, 2010, Neurology.

Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors

P. Sindou, J. Vallat, J. Hugon, 1993, The Lancet.

Ataxia with oculomotor apraxia type 2: A clinical and genetic study of 19 patients

M. Koenig, J. Vallat, D. Grid, 2009, Journal of the Neurological Sciences.

Glutamate dehydrogenase and aspartate aminotransferase in leukocytes of patients with motor neuron disease

J. Vallat, J. Hugon, M. Dumas, 1989, Neurology.

Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations

M. Ruberg, A. Brice, N. Birouk, 2006, Neurology.

Estimation of the amyotrophic lateral sclerosis incidence by capture-recapture method in the Limousin region of France.

M. Druet‐Cabanac, P. Preux, J. Vallat, 2000, Journal of clinical epidemiology.

Clinical, electrophysiologic, and molecular correlations in 13 families with hereditary neuropathy with liability to pressure palsies and a chromosome 17p11.2 deletion

Y. Agid, A. Brice, R. Gouider, 1995, Neurology.

Phenotypic and genetic exploration of severe demyelinating and secondary axonal neuropathies resulting from GDAP1 nonsense and splicing mutations

A. Mégarbané, N. Lévy, J. Vallat, 2003, Journal of medical genetics.

The phenotypic manifestations of autosomal recessive axonalCharcot–Marie–Tooth due to a mutation in Lamin A/C gene

P. Sindou, J. Vallat, D. Grid, 2003, Neuromuscular Disorders.

Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A/C.

P. Sindou, J. Vallat, D. Grid, 2004, Brain : a journal of neurology.

Demyelinating X‐linked Charcot–Marie–Tooth disease: Unusual electrophysiological findings

N. Lévy, P. Sindou, J. Vallat, 1999, Muscle & nerve.

Interferon beta-1a as an investigational treatment for CIDP

P. Preux, P. Bouche, J. Vallat, 2003, Neurology.

Upper limb onset of hereditary transthyretin amyloidosis is common in non‐endemic areas

C. Lacroix, P. Lozeron, V. Algalarrondo, 2018, European journal of neurology.

Homogeneous phenotype of the gypsy limb-girdle MD with the γ-sarcoglycan C283Y mutation

A. Toutain, B. Echenne, L. Kalaydjieva, 2000, Neurology.

[Polyneuropathies in vitamin B1 deficiency in Reunion and Mayotte islands in 70 patients of Maori and Comorian descent].

P. Tournebize, C. Charlin, C. Roussin, 2009, Bulletin de la Societe de pathologie exotique.

Recommendations to enable drug development for inherited neuropathies: Charcot-Marie-Tooth and Giant Axonal Neuropathy [version 2; peer review: 2 approved]

S. Ekins, Lori Sames, Jean-Michel Vallat, 2022 .

La maladie de Charcot-Marie-Tooth

B. Funalot, J. Vallat, Jean-Michel Vallat, 2010 .

Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations

R. Ouvrier, C. Magdelaine, S. Grew, 2008, Neurology.